ATOX BIO
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.
ATOX BIO
Social Links:
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2003-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.atoxbio.com
Total Employee:
11+
Status:
Active
Contact:
97237582807
Email Addresses:
[email protected]
Total Funding:
58.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series F - Atox Bio
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series F - Atox Bio
The Becker Group
The Becker Group investment in Series F - Atox Bio
Asahi Kasei
Asahi Kasei investment in Series F - Atox Bio
Arix Bioscience
Arix Bioscience investment in Series F - Atox Bio
Integra Holdings
Integra Holdings investment in Series F - Atox Bio
OrbiMed
OrbiMed investment in Series F - Atox Bio
Adams Street Partners
Adams Street Partners investment in Series F - Atox Bio
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series E - Atox Bio
SR One
SR One investment in Series E - Atox Bio
